Dorsch Marion
Chief Scientific Officer at BPMC
- Sold, on record
- $5.8M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Feb 22, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BPMCBlueprint Medicines CorpChief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BPMCUnusualDec 19, 2019 2019
Sold 4,600 shares at $79.00 ($363k)
Dorsch Marion, Chief Scientific Officer
Sold 100% of holdings ($363k position)0 shares left2x usual sizeFiling
- 2 Form 4 sale BPMCPlan not statedMar 9, 2020 +81 days
Sold 536 shares at $51.99 ($28k)
Dorsch Marion, Chief Scientific Officer
Sold 3.2% of holdings ($884k position)16,464 shares left0.2x usual sizeFiling
- 3 Form 4 sale BPMCPlan not statedMar 23, 2020 +14 days
Sold 1,214 shares at $52.49 ($64k)
Dorsch Marion, Chief Scientific Officer
Sold 7.4% of holdings ($864k position)15,250 shares left0.5x usual sizeFiling
- 4 Form 4 sale BPMCPlan not statedJun 19, 2020 +88 days
Sold 4,600 shares at $79.00 ($363k)
Dorsch Marion, Chief Scientific Officer
Sold 23.2% of holdings ($1.6M position)15,250 shares left2x usual sizeFiling
- 5 Form 4 sale BPMCPlan not statedSep 23, 2020 +96 days
Sold 4,600 shares at $89.00 ($409k)
Dorsch Marion, Chief Scientific Officer
Sold 23.2% of holdings ($1.8M position)15,250 shares left1.3x usual sizeFiling
- 6 Form 4 sale BPMCPlan not statedOct 6, 2020 +13 days
Sold 4,600 shares at $99.00 ($455k)
Dorsch Marion, Chief Scientific Officer
Sold 23.2% of holdings ($2M position)15,250 shares left1x usual sizeFiling
- 7 Form 4 sale BPMCPlan not statedDec 14, 2020 +69 days
Sold 4,600 shares at $119.00 ($547k)
Dorsch Marion, Chief Scientific Officer
Sold 23.2% of holdings ($2.4M position)15,250 shares left1x usual sizeFiling
- 8 Form 4 sale BPMCUnusualFeb 22, 2021 +70 days
Sold 7,578 shares at $100.00 ($758k)
Dorsch Marion, Chief Scientific Officer
Sold 33.2% of holdings ($2.3M position)15,250 shares left1.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2021 | Feb 24, 2021 | BPMC | Chief Scientific Officer | Form 4 sale | 7,578 | $758k | 33.2% | Unusual | SEC |
| Dec 14, 2020 | Dec 16, 2020 | BPMC | Chief Scientific Officer | Form 4 sale | 4,600 | $547k | 23.2% | Plan not stated | SEC |
| Oct 6, 2020 | Oct 8, 2020 | BPMC | Chief Scientific Officer | Form 4 sale | 4,600 | $455k | 23.2% | Plan not stated | SEC |
| Sep 23, 2020 | Sep 25, 2020 | BPMC | Chief Scientific Officer | Form 4 sale | 4,600 | $409k | 23.2% | Plan not stated | SEC |
| Jun 19, 2020 | Jun 23, 2020 | BPMC | Chief Scientific Officer | Form 4 sale | 4,600 | $363k | 23.2% | Plan not stated | SEC |
| Mar 23, 2020 | Mar 25, 2020 | BPMC | Chief Scientific Officer | Form 4 sale | 1,214 | $64k | 7.4% | Plan not stated | SEC |
| Mar 9, 2020 | Mar 11, 2020 | BPMC | Chief Scientific Officer | Form 4 sale | 536 | $28k | 3.2% | Plan not stated | SEC |
| Dec 19, 2019 | Dec 23, 2019 | BPMC | Chief Scientific Officer | Form 4 sale | 4,600 | $363k | 100.0% | Unusual | SEC |
| Jun 17, 2019 | Jun 19, 2019 | BPMC | Chief Scientific Officer | Form 4 sale | 4,600 | $455k | 100.0% | Unusual | SEC |
| Mar 4, 2019 | Mar 6, 2019 | BPMC | Chief Scientific Officer | Form 4 sale | 2,300 | $195k | 100.0% | Unusual | SEC |
| Sep 17, 2018 | Sep 19, 2018 | BPMC | Chief Scientific Officer | Form 4 sale | 2,300 | $162k | 100.0% | Unusual | SEC |
| Mar 15, 2018 | Mar 19, 2018 | BPMC | Chief Scientific Officer | Form 4 sale | 2,300 | $230k | 100.0% | Unusual | SEC |
| Nov 22, 2017 | Nov 24, 2017 | BPMC | Chief Scientific Officer | Form 4 sale | 9,166 | $642k | 100.0% | Unusual | SEC |
| Nov 21, 2017 | Nov 22, 2017 | BPMC | Chief Scientific Officer | Form 4 sale | 17,834 | $1.2M | 97.3% | Unusual | SEC |